Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing
- PMID: 2734021
Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing
Erratum in
- Oncogene 1989 Nov;4(11):1415
Abstract
We previously reported the cloning of a transforming gene, ret-II, which contains the proto-ret kinase domain. In the present study ret-II cDNAs were cloned from a transformant and analyzed. The restriction map and nucleotide sequence indicated that the sequence upstream of the proto-ret kinase domain was replaced by another sequence, which encoded a fusion protein composed of 899 amino acids. This non-proto-ret sequence differed from that of the ret previously reported and had no hydrophobic amino acid stretch for a transmembrane domain. Furthermore, we obtained two kinds of ret-II cDNAs differing in their 3' regions and found that the differences were generated by alternative splicing. From these cDNAs, two types of oncogene products differing in their carboxy-terminal amino acid residues were predicted. The two products exhibited similar transforming activity in NIH3T3 cells. These data indicate that activation of proto-ret can occur as a result of replacement of the extra-cellular and transmembrane domains with the hydrophilic sequence. In addition, differences in the carboxy-terminal amino acid residues in the two types of ret-II oncogene products have no influence on the transforming activity of the ret-II oncogene.
Similar articles
-
Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.Oncogene. 1988 Nov;3(5):571-8. Oncogene. 1988. PMID: 3078962
-
Molecular cloning and characterization of human ret-II oncogene.Oncogene Res. 1988 Sep;3(2):193-7. Oncogene Res. 1988. PMID: 3226727
-
cDNA cloning and characterization of ret activated in a human papillary thyroid carcinoma cell line.Biochem Biophys Res Commun. 1990 Apr 30;168(2):402-8. doi: 10.1016/0006-291x(90)92335-w. Biochem Biophys Res Commun. 1990. PMID: 2334411
-
Cloning of an activated human ret gene with a novel 5' sequence fused by DNA rearrangement.Gene. 1991 Nov 15;107(2):323-8. doi: 10.1016/0378-1119(91)90334-8. Gene. 1991. PMID: 1748302
-
[Transforming activity and protein kinase activity of p60c-src].Seikagaku. 1986 Feb;58(2):118-23. Seikagaku. 1986. PMID: 3011925 Review. Japanese. No abstract available.
Cited by
-
RET signaling pathway and RET inhibitors in human cancer.Front Oncol. 2022 Jul 25;12:932353. doi: 10.3389/fonc.2022.932353. eCollection 2022. Front Oncol. 2022. PMID: 35957881 Free PMC article. Review.
-
Mutation Profile of Well-Differentiated Thyroid Cancer in Asians.Endocrinol Metab (Seoul). 2015 Sep;30(3):252-62. doi: 10.3803/EnM.2015.30.3.252. Endocrinol Metab (Seoul). 2015. PMID: 26435130 Free PMC article. Review.
-
The many faces of RET dysfunction in kidney.Organogenesis. 2009 Oct;5(4):177-90. doi: 10.4161/org.5.4.10048. Organogenesis. 2009. PMID: 20539737 Free PMC article.
-
Cooperating cancer-gene identification through oncogenic-retrovirus-induced insertional mutagenesis.Blood. 2005 Oct 1;106(7):2498-505. doi: 10.1182/blood-2004-12-4840. Epub 2005 Jun 16. Blood. 2005. PMID: 15961513 Free PMC article.
-
Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase.Mol Cell Biol. 1993 Nov;13(11):6711-22. doi: 10.1128/mcb.13.11.6711-6722.1993. Mol Cell Biol. 1993. PMID: 8413267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases